Phase II and pharmacokinetic trial of rebeccamycin analog [becatecarin] in hepatobiliary cancers
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2010
At a glance
- Drugs Becatecarin (Primary)
- Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer; Liver cancer
- Focus Therapeutic Use
- 27 Apr 2010 Actual patient number (72) added as reported by ClinicalTrials.gov.
- 02 Mar 2010 Actual end date (Nov 2005) added as reported by ClinicalTrials.gov.
- 17 Sep 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History